Biotechnology stocks
1,365 listed biotechnology companies, ordered by market capitalisation, inside the Health Care sector. Every one has a free page with its price history, key figures and Tweenvest factor scores.
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $479.52B | $271.99 | +0.23% |
| Amgen Inc.NasdaqGS: AMGN | $223.32B | $406.95 | -1.48% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $182.09B | $147.19 | +0.23% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $128.16B | $505.45 | -0.04% |
| Moderna, Inc.NasdaqGS: MRNA | $78.44B | $197.35 | +0.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $74.10B | $736.93 | -0.70% |
| CSL LimitedASX: CSL | $60.66B | AU$181.99 | +1.85% |
| argenx SEENXTBR: ARGX | $58.70B | €705.60 | -15.86% |
| Natera, Inc.NasdaqGS: NTRA | $57.02B | $389.72 | -1.48% |
| Revolution Medicines, Inc.NasdaqGS: RVMD | $43.05B | $188.60 | -6.11% |
| BeOne Medicines AGNasdaqGS: ONC | $41.39B | $364.02 | +0.34% |
| Biogen Inc.NasdaqGS: BIIB | $32.82B | $217.43 | -2.12% |
| Celltrion, Inc.KOSE: A068270 | $30.97B | ₩182,600.00 | +2.93% |
| Alnylam Pharmaceuticals, Inc.NasdaqGS: ALNY | $30.03B | $224.55 | +0.06% |
| Roivant Sciences Ltd.NasdaqGS: ROIV | $25.10B | $34.44 | -0.91% |
| BioNTech SENasdaqGS: BNTX | $23.93B | $92.11 | -3.30% |
| United Therapeutics CorporationNasdaqGS: UTHR | $23.38B | $536.98 | -1.47% |
| Incyte CorporationNasdaqGS: INCY | $22.99B | $113.14 | -0.26% |
| Genmab A/SCPSE: GMAB | $22.24B | Dkr2,356.00 | -5.27% |
| Insmed IncorporatedNasdaqGS: INSM | $22.22B | $100.24 | -1.47% |
| Innovent Biologics, Inc.SEHK: 1801 | $21.63B | HK$97.50 | -1.86% |
| PharmaEssentia CorporationTWSE: 6446 | $15.16B | NT$1,165.00 | +0.87% |
| Ascendis Pharma A/SNasdaqGS: ASND | $15.00B | $224.11 | -1.88% |
| Swedish Orphan Biovitrum AB (publ)OM: SOBI | $14.83B | Skr422.40 | -1.26% |
| Neurocrine Biosciences, Inc.NasdaqGS: NBIX | $14.58B | $141.60 | -1.31% |
| Exelixis, Inc.NasdaqGS: EXEL | $14.48B | $59.60 | +1.98% |
| Summit Therapeutics Inc.NasdaqGM: SMMT | $14.36B | $17.20 | -4.21% |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.SEHK: 6990 | $14.27B | HK$468.60 | -1.97% |
| ALTEOGEN Inc.KOSDAQ: A196170 | $13.42B | ₩259,500.00 | +3.80% |
| BridgeBio Pharma, Inc.NasdaqGS: BBIO | $13.00B | $65.17 | -2.00% |
| Halozyme Therapeutics, Inc.NasdaqGS: HALO | $12.57B | $110.44 | -0.32% |
| Akeso, Inc.SEHK: 9926 | $12.54B | HK$106.80 | +14.16% |
| Madrigal Pharmaceuticals, Inc.NasdaqGS: MDGL | $11.54B | $479.36 | -4.01% |
| BioMarin Pharmaceutical Inc.NasdaqGS: BMRN | $10.69B | $54.86 | -0.62% |
| ImmunityBio, Inc.NasdaqGS: IBRX | $10.33B | $9.85 | +1.03% |
| Vaxcyte, Inc.NasdaqGS: PCVX | $9.96B | $65.77 | -1.78% |
| Twist Bioscience CorporationNasdaqGS: TWST | $9.76B | $148.55 | -4.56% |
| Krystal Biotech, Inc.NasdaqGS: KRYS | $9.61B | $331.83 | +2.24% |
| Protagonist Therapeutics, Inc.NasdaqGM: PTGX | $9.12B | $140.73 | -0.13% |
| Kymera Therapeutics, Inc.NasdaqGM: KYMR | $8.93B | $109.54 | +2.00% |
| Arrowhead Pharmaceuticals, Inc.NasdaqGS: ARWR | $8.68B | $61.04 | -0.72% |
| Cytokinetics, IncorporatedNasdaqGS: CYTK | $8.50B | $62.43 | +2.14% |
| Praxis Precision Medicines, Inc.NasdaqGS: PRAX | $8.25B | $264.99 | -10.33% |
| Spyre Therapeutics, Inc.NasdaqGS: SYRE | $8.22B | $80.49 | -13.63% |
| RemeGen Co., Ltd.SEHK: 9995 | $8.12B | HK$72.90 | -2.41% |
| TG Therapeutics, Inc.NasdaqCM: TGTX | $7.70B | $53.86 | -0.79% |
| ABIVAX Société AnonymeENXTPA: ABVX | $7.67B | €78.60 | -5.87% |
| Caris Life Sciences, Inc.NasdaqGS: CAI | $7.66B | $27.25 | +0.55% |
| Ionis Pharmaceuticals, Inc.NasdaqGS: IONS | $7.34B | $43.22 | -2.13% |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd.SEHK: 2315 | $7.31B | HK$67.45 | -1.24% |
| Alkermes plcNasdaqGS: ALKS | $6.95B | $40.29 | -2.79% |
| Gan & Lee Pharmaceuticals.SHSE: 603087 | $6.87B | CN¥77.40 | +5.39% |
| Grifols, S.A.BME: GRF | $6.66B | €9.68 | -2.69% |
| Immunovant, Inc.NasdaqGS: IMVT | $6.62B | $30.71 | -4.15% |
| Rhythm Pharmaceuticals, Inc.NasdaqGM: RYTM | $6.39B | $89.79 | -3.27% |
| Biocon LimitedNSEI: BIOCON | $6.27B | Rs370.70 | -3.00% |
| Kiniksa Pharmaceuticals International, plcNasdaqGS: KNSA | $6.08B | $78.52 | +0.72% |
| GRAIL, Inc.NasdaqGS: GRAL | $5.94B | $132.20 | -0.53% |
| Kodiak Sciences Inc.NasdaqGM: KOD | $5.92B | $94.24 | -0.22% |
| Iovance Biotherapeutics, Inc.NasdaqGM: IOVA | $5.85B | $13.35 | +3.33% |
| Oruka Therapeutics, Inc.NasdaqCM: ABIO | $5.60B | $— | — |
| Oruka Therapeutics, Inc.NasdaqGM: ORKA | $5.60B | $77.28 | -8.57% |
| Sunshine Guojian Pharmaceutical (Shanghai) Co., LtdSHSE: 688336 | $5.54B | CN¥41.43 | +5.66% |
| CG Oncology, Inc.NasdaqGS: CGON | $5.53B | $63.60 | +1.96% |
| Mirum Pharmaceuticals, Inc.NasdaqGM: MIRM | $5.38B | $81.90 | -1.24% |
| Travere Therapeutics, Inc.NasdaqGM: TVTX | $5.37B | $52.29 | -8.15% |
| PTC Therapeutics, Inc.NasdaqGS: PTCT | $5.28B | $62.56 | -1.06% |
| Cogent Biosciences, Inc.NasdaqGS: COGT | $5.23B | $30.49 | +1.16% |
| Shanghai RAAS Blood Products Co., Ltd.SZSE: 002252 | $5.23B | CN¥5.32 | +5.98% |
| Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.SHSE: 603392 | $5.15B | CN¥27.34 | +3.64% |
| Scholar Rock Holding CorporationNasdaqGS: SRRK | $5.14B | $42.40 | +0.47% |
| CRISPR Therapeutics AGNasdaqGM: CRSP | $5.06B | $50.43 | -3.67% |
| Chongqing Zhifei Biological Products Co., Ltd.SZSE: 300122 | $4.99B | CN¥13.98 | +7.46% |
| 3SBio Inc.SEHK: 1530 | $4.99B | HK$15.70 | -1.94% |
| Erasca, Inc.NasdaqGS: ERAS | $4.94B | $15.55 | +10.09% |
| Dianthus Therapeutics, Inc.NasdaqCM: DNTH | $4.75B | $82.71 | -2.56% |
| Lin BioScience, Inc.TPEX: 6696 | $4.72B | NT$181.50 | -8.33% |
| Shanghai Junshi Biosciences Co., Ltd.SEHK: 1877 | $4.67B | HK$18.07 | -1.31% |
| Suzhou Zelgen Biopharmaceuticals Co., Ltd.SHSE: 688266 | $4.34B | CN¥110.00 | +0.96% |
| Imeik Technology Development Co.,Ltd.SZSE: 300896 | $4.27B | CN¥95.00 | +3.34% |
| Shanghai Henlius Biotech, Inc.SEHK: 2696 | $4.06B | HK$58.40 | +2.10% |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd.SHSE: 688192 | $4.02B | CN¥58.01 | +2.76% |
| Relay Therapeutics, Inc.NasdaqGM: RLAY | $3.93B | $17.48 | -2.62% |
| Tango Therapeutics, Inc.NasdaqGM: TNGX | $3.92B | $22.56 | -2.93% |
| Telix Pharmaceuticals LimitedASX: TLX | $3.75B | AU$15.87 | +2.99% |
| Beijing Tiantan Biological Products Co., Ltd.SHSE: 600161 | $3.71B | CN¥12.59 | +4.05% |
| Legend Biotech CorporationNasdaqGS: LEGN | $3.70B | $18.58 | -2.85% |
| Xenon Pharmaceuticals Inc.NasdaqGM: XENE | $3.68B | $36.28 | -4.58% |
| InnoCare Pharma LimitedSEHK: 9969 | $3.67B | HK$13.63 | -4.62% |
| Hualan Biological Engineering Inc.SZSE: 002007 | $3.63B | CN¥13.34 | +1.75% |
| Celcuity Inc.NasdaqCM: CELC | $3.53B | $67.91 | -5.81% |
| Acrobiosystems Co.,Ltd.SZSE: 301080 | $3.52B | CN¥141.07 | +16.19% |
| IDEAYA Biosciences, Inc.NasdaqGS: IDYA | $3.50B | $36.13 | -0.36% |
| Veracyte, Inc.NasdaqGM: VCYT | $3.47B | $43.16 | 0.00% |
| Walvax Biotechnology Co., Ltd.SZSE: 300142 | $3.39B | CN¥14.23 | +4.79% |
| Acadia Pharmaceuticals Inc.NasdaqGS: ACAD | $3.39B | $19.60 | -0.28% |
| Viking Therapeutics, Inc.NasdaqCM: VKTX | $3.33B | $27.69 | -2.98% |
| CareDx, Inc.NasdaqGM: CDNA | $3.26B | $62.26 | -1.24% |
| Evopoint Biosciences Co., Ltd.SHSE: 688837 | $3.21B | CN¥49.40 | 0.00% |
| Xiamen Amoytop Biotech Co., Ltd.SHSE: 688278 | $3.13B | CN¥52.89 | +2.90% |